Comment on

• Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians.

  Qaseem A, Hopkins RH Jr, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Qaseem A, et al. Ann Intern Med. 2013 Dec 17;159(12):835-47. doi: 10.7326/0003-4819-159-12-201312170-00726. Ann Intern Med. 2013. PMID: 24145991
• Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease.

  Dhar GC. Dhar GC. Ann Intern Med. 2014 Jul 1;161(1):81. doi: 10.7326/L14-5013. Ann Intern Med. 2014. PMID: 24979455 No abstract available.
• Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease.

  Levin A, Stevens PE, Coresh J, Levey A. Levin A, et al. Ann Intern Med. 2014 Jul 1;161(1):81-2. doi: 10.7326/L14-5013-2. Ann Intern Med. 2014. PMID: 24979456 No abstract available.
• Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease.

  Lambers Heerspink HJ, Gaillard CJ, Gansevoort RT. Lambers Heerspink HJ, et al. Ann Intern Med. 2014 Jul 1;161(1):82-3. doi: 10.7326/L14-5013-3. Ann Intern Med. 2014. PMID: 24979457 No abstract available.
• Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease.

  Abdel-Kader K. Abdel-Kader K. Ann Intern Med. 2014 Jul 1;161(1):83. doi: 10.7326/L14-5013-4. Ann Intern Med. 2014. PMID: 24979458 No abstract available.